Details of Drug-Drug Interaction
| Drug General Information (ID: DDIJDAYP8G) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Netilmicin | Drug Info | Mycophenolic acid | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antibiotics | Antiviral Agents | |||||||
| Structure | |||||||||
| Mechanism of Netilmicin-Mycophenolic acid Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Altered intestinal flora Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Netilmicin | Mycophenolic acid | |||||||
| Mechanism | Alters GI flora | Affected by alters GI flora | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Intestinal flora | ||||||||
| Factor Description | The intestinal flora has multiple effects on human health, and altering the intestinal microbiota can affect the absorption of drugs and alter their pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Close clinical and laboratory monitoring for evidence of diminished immunosuppressive effect of mycophenolic acid is recommended during concomitant therapy with anti-infective agents. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ. | ||||||||||||||||||
| 2 | Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ. | ||||||||||||||||||

